Makena Class Action Settlement — $7.5M Payment Status

View Open Settlements
Prescription Drug · Payments Reported

Makena Class Action Settlement: $7.5M Fund, Final Approval, and Payment Status

By Steve Levine

Makena settlement PayPal payments reported June 2026 — Maher v. AMAG Pharmaceuticals class action

Published: October 21, 2025 · Updated: June 11, 2026

Status Closed to Claims · Final Approval Granted · Payments Reported
Claim Deadline November 10, 2025 (passed)
Final Approval Granted January 2026 Final approval hearing held January 12, 2026
Payment Status Payments Reported June 2026 Payments are being reported in June 2026, including PayPal payments · paper checks may take longer · from the $7,500,000 fund, paid pro rata
Payment reports are coming in: Some Makena settlement claimants are reporting PayPal payments in June 2026. If you have not received payment yet, check the payment method you selected on your claim form and contact the official settlement administrator for claim-specific help.
June 2026 Payment Update
Some Makena settlement claimants are now reporting that they received PayPal payments in June 2026. These reports are consistent with the official settlement website's prior statement that distribution was expected by the end of May 2026. However, OpenClassActions.com has not independently verified that all payments have been issued, and payment timing may vary depending on claim approval status and the payment method selected on the claim form.

If you filed a valid claim and have not received payment yet, check your email, spam folder, PayPal account, and mail. You can also check your claim or payment status through the official Makena settlement website or contact the settlement administrator directly. OpenClassActions.com is not the settlement administrator and cannot check individual claims, resend payments, confirm payment amounts, or update payment methods.

Read our latest Makena PayPal payment update for what claimants are reporting and what to check if your payment hasn't arrived.

What Was This Settlement About?

This was a $7,500,000 class action settlement reached with AMAG Pharmaceuticals, Inc. over allegations that AMAG misrepresented Makena's effectiveness at reducing the risk of preterm birth. The FDA approved Makena in 2011 and withdrew approval in April 2023 after a post-marketing study did not confirm efficacy. AMAG denied wrongdoing, and the court did not decide who was right or wrong. The parties agreed to settle to avoid the cost and uncertainty of further litigation. The claim deadline was November 10, 2025 and has passed, the court granted final approval after the January 12, 2026 hearing, and the official settlement website states that distribution was expected by the end of May 2026. This page is now for informational and status purposes only.

Can I Still File a Claim?

No. The deadline to submit a claim, opt out, or object was November 10, 2025, and it has passed. If you are looking for settlements you can still file, see our list of open class action settlements.

Who Was Eligible?

The settlement class covered natural persons in the United States who took, were prescribed, purchased, paid for, or otherwise incurred out-of-pocket costs in connection with treatment with Makena from March 8, 2019 through July 11, 2025. Exclusions applied for the Court, the Defendant and its affiliates, counsel, and anyone who validly opted out.

Covered Products

Makena (hydroxyprogesterone caproate injection) in any dose or formulation, whether single or multi-dose vials or auto-injector, including NDCs 64011-243-01, 64011-247-02, and 64011-301-03. Generic or compounded versions were not covered.

How Much Could Class Members Get?

Payments came from the $7,500,000 Settlement Fund and could be increased or decreased pro rata so that total payments equaled the available funds after fees, costs, and service awards.

With Proof of Treatment and Proof of Out-of-Pocket Payment: $22 per treatment during the Class Period. If you participated in a Government Healthcare Program at the time of treatment, $4 per treatment. Subject to pro rata adjustment.

Without proof: $1 per treatment, up to a $40 maximum. Subject to pro rata adjustment.

Class members could file without proofs; providing Proof of Treatment and Proof of Out-of-Pocket Payment (medical or pharmacy records and receipts showing Makena treatments and what was personally paid) could increase the payment.

What Is Makena?

Makena was a prescription hormone injection made to help lower the risk of preterm birth in pregnant women with a history of early delivery. It was approved by the FDA in 2011 but later found to be ineffective; the FDA officially withdrew its approval in 2023 after studies showed no clear benefit. AMAG Pharmaceuticals, a Massachusetts-based drug company, developed and sold Makena and was later acquired by Covis Pharma, which continued selling the drug until it was pulled from the market.

When Will Makena Settlement Payments Be Made?

Payments were expected after final approval and claim review, issued by the method each class member selected on the Claim Form. The court granted final approval after the January 12, 2026 hearing in Newark, New Jersey, and the official settlement website previously stated that distribution was expected by the end of May 2026. As of June 2026, some claimants are now reporting PayPal payments. This suggests distribution may have begun, but OpenClassActions.com has not confirmed that every approved claimant has been paid. People who selected paper checks may receive payment later than people who selected PayPal or another electronic payment method. If you submitted a valid claim and have not yet received your payment, the most reliable way to confirm your status is to check directly with the Makena Claim Administrator through the official settlement website. OpenClassActions.com is not the settlement administrator and cannot look up or release individual claim or payment information.

What Are My Options Now?

The windows for taking action in this case have closed, so for most class members the only remaining question is the status of their payment. The key dates have all passed: the claim submission deadline, the opt-out deadline, and the objection deadline were all November 10, 2025, and the final approval hearing took place on January 12, 2026. Because the deadline to exclude yourself or object is behind us, class members who filed a valid claim simply wait for their payment — distribution appears to have begun, with some claimants reporting PayPal payments in June 2026 — while anyone who did not file a claim by the deadline is no longer eligible to receive a payment from this settlement.

Frequently Asked Questions

Can I still file a Makena settlement claim?
No. The claim deadline was November 10, 2025 and has passed. New claims are no longer being accepted.

Are Makena settlement payments going out?
Yes, payments are now being reported by some claimants in June 2026, including PayPal payments. However, payment timing may vary depending on claim approval status and the payment method selected. OpenClassActions.com is not the settlement administrator and cannot verify individual payments.

Why did someone else get a Makena PayPal payment but I did not?
Payment timing can vary based on the payment method selected, claim review status, PayPal account details, email delivery, and whether a claimant selected paper check instead of PayPal. Check your email, spam folder, PayPal account, and physical mail, then contact the settlement administrator if you still need help.

Are paper checks being mailed for the Makena settlement?
The settlement notice said payments would be issued through the method selected on the claim form. If you selected paper check, your payment may arrive later than PayPal or other electronic payments.

Can OpenClassActions.com check my Makena payment?
No. OpenClassActions.com is not the settlement administrator. We cannot check individual claim status, confirm payment amounts, change payment methods, or resend payments. Claimants should contact the official Makena settlement administrator.

What was the total settlement amount?
$7,500,000, paid into a Settlement Fund for eligible claimants, notice and administration, attorneys' fees, and service awards.

Who was eligible for the Makena settlement?
People in the U.S. who took, were prescribed, purchased, paid for, or incurred out-of-pocket costs for Makena between March 8, 2019 and July 11, 2025, subject to exclusions.

How much could class members get paid?
With proof of treatment and out-of-pocket payment, $22 per treatment (or $4 per treatment with a Government Healthcare Program); with no proofs, $1 per treatment up to $40. All amounts were subject to pro rata adjustment.

Did the settlement cover generic versions of Makena?
No. It covered brand Makena only; compounded or generic hydroxyprogesterone caproate was not included.

Official Settlement Notice

Your browser does not support viewing PDFs inline. Download the PDF.



Sources

Official settlement website (Makena Settlement.com)
• U.S. District Court for the District of New Jersey, Maher v. AMAG Pharmaceuticals, Inc., Case No. 2:20-cv-00152-JXN-JBC

For more class actions keep scrolling below.
Status Closed to Claims · Final Approval Granted · Payments Reported
Settlement Amount $7,500,000
Claim Deadline November 10, 2025 (passed)
Final Approval Granted January 2026 Hearing held January 12, 2026 · Newark, NJ
Payment Status Payments Reported June 2026 Some claimants are reporting PayPal payments. Paper checks may take longer. Check with the official administrator for individual claim status.
Case Title Maher v. AMAG Pharmaceuticals, Inc.
Case Number 2:20-cv-00152-JXN-JBC
Court U.S. District Court, District of New Jersey
Class Period March 8, 2019 – July 11, 2025
Official Website Makena Settlement.com